The Prevalence of Parent-Reported Autism Spectrum Disorder Among US Children
The Prevalence of Parent-Reported Autism Spectrum Disorder Among US Children
复制标题
DOI：
10.1542/peds.2017-4161
复制
发表时间：
2018-12-01
期刊：
影响因子：
8
通讯作者：
Lu, Michael C.
中科院分区：
文献类型：
--
作者：
Kogan, Michael D.;Vladutiu, Catherine J.;Lu, Michael C.
目的：使用2016年全国儿童健康调查（NSCH）估计3至17岁美国儿童中父母报告的自闭症谱系障碍（ASD）诊断的全国患病率以及他们的治疗和医疗保健经验。2016年NSCH是一项全国代表性的调查，涉及50212名儿童，重点关注0至17岁儿童的健康和福祉。NSCH收集了父母报告的信息，包括儿童是否接受过护理提供者的ASD诊断，目前的ASD状态，医疗保健使用，访问和挑战以及治疗方法。我们计算了加权患病率估计ASD，比较与其他儿童ASD的儿童的医疗保健经验，并检查与药物和行为治疗的可能性增加相关的因素。结果：父母的估计150万美国儿童年龄在3至17岁（2.50%）报告说，他们的孩子曾经接受过ASD诊断，目前有条件。与其他情绪或行为障碍（注意力缺陷/多动障碍，焦虑，行为或行为问题，抑郁，发育迟缓，唐氏综合征，智力障碍，学习障碍，妥瑞氏综合征）和没有这些条件的儿童相比，父母报告ASD诊断的儿童更有可能有更大的医疗保健需求和获得医疗保健的困难。在目前患有ASD的儿童中，27%的儿童正在服用ASD相关症状的药物，而64%的儿童在过去12个月内接受了行为治疗，这些治疗因社会人口特征和共同发生的情况而异。据估计，父母报告的ASD诊断的美国儿童的患病率现在是1/40，ASD特异性治疗的使用率因儿童的社会人口统计学和共同发生的条件而异。
OBJECTIVES: To estimate the national prevalence of parent-reported autism spectrum disorder (ASD) diagnosis among US children aged 3 to 17 years as well as their treatment and health care experiences using the 2016 National Survey of Children's Health (NSCH).METHODS: The 2016 NSCH is a nationally representative survey of 50 212 children focused on the health and well-being of children aged 0 to 17 years. The NSCH collected parent-reported information on whether children ever received an ASD diagnosis by a care provider, current ASD status, health care use, access and challenges, and methods of treatment. We calculated weighted prevalence estimates of ASD, compared health care experiences of children with ASD to other children, and examined factors associated with increased likelihood of medication and behavioral treatment.RESULTS: Parents of an estimated 1.5 million US children aged 3 to 17 years (2.50%) reported that their child had ever received an ASD diagnosis and currently had the condition. Children with parent-reported ASD diagnosis were more likely to have greater health care needs and difficulties accessing health care than children with other emotional or behavioral disorders (attention-deficit/hyperactivity disorder, anxiety, behavioral or conduct problems, depression, developmental delay, Down syndrome, intellectual disability, learning disability, Tourette syndrome) and children without these conditions. Of children with current ASD, 27% were taking medication for ASD-related symptoms, whereas 64% received behavioral treatments in the last 12 months, with variations by sociodemographic characteristics and co-occurring conditions.CONCLUSIONS: The estimated prevalence of US children with a parent-reported ASD diagnosis is now 1 in 40, with rates of ASD-specific treatment usage varying by children's sociodemographic and co-occurring conditions.